Skip to main content
Fig. 5 | Stem Cell Research & Therapy

Fig. 5

From: Machine learning-identified stemness features and constructed stemness-related subtype with prognosis, chemotherapy, and immunotherapy responses for non-small cell lung cancer patients

Fig. 5

TIDE predicts immunotherapy response between cancer types. A Survival difference between the two groups of high and low TIDE, green indicates low TIDE score, red indicates high TIDE score. B Distribution of different cancer subtypes between two groups of high and low TIDE, sky blue indicates LUAD, brown indicates LUSC. C TIDE difference between cancer subtypes, green indicates LUAD, yellow indicates LUSC, ****indicates P value < 0.0001. D Submap analysis demonstrating the predicted efficacy of different cancer subtypes in immunotherapy

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512